In our study, in vivo experiments demonstrated that the supplementation of hesperetin with metformin elevated acetic acid, propionic acid, and butyric acid content, leading to improved cognitive impairment in DM rats through the protection of insulin signaling and the activation of CREB/BDNF (Figure 6). The gene discussed is CREB1; the disease is Cognitive impairment.